Newsroom

Bactéries vivantes : « Le monde de la pharma se penche sur le microbiome »

Dec 7, 2020

YSOPIA Bioscience Announces Enrollment and Treatment of First Volunteers in its Phase 1 Clinical...

Dec 7, 2020

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...

Nov 17, 2020

We are looking for a R&D Microbiologist

Oct 13, 2020

La société innovante bordelaise LNC Therapeutics devient Ysopia Bioscience

Oct 2, 2020

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020